Sort
261,768 grants matching “gene therapy”
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
$1,129,400David M Holtzman · Washington University · P01 · FY2014 · NS
MODELS OF HUMAN IMMUNODEFICIENCIES
$1,129,386Beth Israel Deaconess Medical Center · P01 · FY2001 · AI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,129,373Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · CA
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
$1,129,362David M Holtzman · Washington University · P01 · FY2015 · NS
Primary Immune Deficiency Clinic
$1,129,315Alexandra Freeman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Clinical, Immunological and Genetic Analyses of ALPS and Related Immunedysregulatory Disorders
$1,129,315V Koneti Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
$1,129,078Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2019 · CA
HIV-1 Maturation
$1,129,032Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Novel Mechanistic Targets of Steroid Hormones in the Brain
$1,128,969Meharvan Singh · University Of North Texas Hlth Sci Ctr · P01 · FY2014 · AG
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
$1,128,851David Elihu Greenberg · Ut Southwestern Medical Center · R01 · FY2020 · AI
Vaccines and Therapeutics for Anthrax
$1,128,820Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CMG2 as a target for safe and effective treatment of endometriosis-associate pain
$1,128,672Michael Sean Rogers · Boston Children'S Hospital · R01 · FY2025 · HD
The mutational mechanism responsible for the Repeat Expansion Diseases
$1,128,672Karen P. Usdin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Molecular Cytogenetics of Solid Tumors
$1,128,669Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Biology of Arrhythmia Susceptibility
$1,128,663Vanderbilt University · P01 · FY2002 · HL
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,128,637Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Identification of Novel Mutations In Pediatric Cancers
$1,128,637Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
PA-50/PA-41 antitoxin antibody therapy for C. difficile infection
$1,128,535William C Olson · Progenics Pharmaceuticals, Inc. · R01 · FY2012 · AI
Thyroid Hormone Receptors in Health and Disease
$1,128,499Sheue-Yann Cheng · Basic Sciences · Z01 · FY2007 · CA
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
$1,128,467Mark H Tuszynski · University Of California, San Diego · R01 · FY2023 · AG
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$1,128,458Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimerâs disease
$1,128,405Hariom Yadav · University Of South Florida · RF1 · FY2021 · AG
Pennington/Louisiana NORC
$1,128,389Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2021 · DK
Engineering and Imaging 3D genome structure-function dynamics across time scales
$1,128,347Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · U01 · FY2021 · DK
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$1,128,123William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA